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Granulomatosis with polyangiitis:
a 17 year experience from a tertiary care
hospital in Pakistan
Omar Irfan1*, Haris Khan1, Zarrar Khan2, Alina Ashraf3, Rimsha Ahmed3, Javaid Ahmad Khan4
and Ali Bin Sarwar Zubairi4

Abstract
Objective: Granulomatosis with Polyangiitis (GPA) is an autoimmune, multi-system, small and medium vessel vasculitis with granulomatous inflammation. Aim of this study was to assess the clinical and radiological presentations of
patients with GPA amongst the Pakistani population. It is a single centre retrospective single observation study.
Results: Study was conducted at the Aga Khan University Hospital, Karachi with records were reviewed from January
2000 to December 2017. Definitive diagnosis was made using a combination of serological anti-neutrophil cytoplasmic antibody (ANCA) testing along with the clinical and radiological presentation. A total of 51 patients met the diagnostic criteria in the time frame of the study. There were 23 males and 28 females with mean age of 44.0 ± 17.8 years
on presentation. Arthritis was the most common symptom present in 41.2% of the cases followed by cough in 32.0%.
Sixteen patients showed pulmonary infiltrates on chest X-ray. C-ANCA was positive in all of the patients compared
with 21.6% p-ANCA positivity. A total of 13 biopsies were done. The median Birmingham Vasculitis Activity Score was
12. We report a 17.6% mortality rate with 5 deaths occurring due to respiratory failure. GPA is a diagnostic challenge
leading to late diagnosis which can contribute to significant morbidity and mortality specially in the Third World.
Keywords: Granulomatosis with polyangiitis, Vasculitis, c-ANCA, p-ANCA
Introduction
GPA is an autoimmune small vessel vasculitis associated
with anti-neutrophil cytoplasmic antibodies (ANCA).
The clinical manifestations include systemic necrotising vasculitis, necrotising glomerulonephritis and
necrotising granulomatous inflammation. GPA was first
described in the literature in a case report in the late
nineteenth century and was previously known as Wegener’s Granulomatosis [1]. While it is uncommon overall, a
significant geographical variation has been observed in
the prevalence of this disease. A latitudinal gradient has
been identified with increasing trend in prevalence as the
distance from the Equator increases [2].

*Correspondence: omarirfan1@hotmail.com
1
Department of Medicine, Aga Khan University, Stadium Road,
Karachi 74800, Pakistan
Full list of author information is available at the end of the article

In GPA, ANCA is mainly directed against Proteinase
3 (PR3); there is strong evidence from various in vitro
studies that ANCA plays a crucial role in the mediation
of small vessel vasculitis [3]. GPA usually starts as a localized granulomatous inflammation of the respiratory tract
that later generalizes into small vessel vasculitis [4, 5].
Older age, pulmonary and kidney involvement are features associated with poor prognosis and increased mortality [6]. The first case of GPA was reported by a German
clinician, Heinz Klinger in 1931 who believed it to be
a variant of polyarteritis nodosa, but it was Friedrich
Wegener who proposed this as a separate pathology
based upon the post mortem findings seen in three of his
patients [7, 8] Several large case series on GPA have been
published from various countries, with the largest series
reporting 445 patients from Germany [9]. This is the first
large institutional experience on the clinical manifestations of GPA patients amongst the Pakistani population.
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We report a series of 51 cases from our institution. Our
study focuses on the clinical and imaging features of GPA
with the hope that it will assist clinicians in better identifying and managing this condition. We also summarize
the compare the clinical features of our patients with
those from other ethnic group studies from literature in
a tabulated form.

Main text
Methods

A retrospective, observational study was conducted at
the Aga Khan University Hospital (AKUH), Karachi.
Records of all patients diagnosed with GPA from January 2000 to December 2017 were reviewed. Age, gender,
clinical features at the time of diagnosis, laboratory and
histo-pathological findings, imaging, type of treatment,
response to treatment and complications were collected
in a predesigned questionnaire. The files were retrieved
using international classification of diseases-9 (ICD-9)
coding. No experimentation on Human and animals was
done. This study was approved by the local ethical committee of the institution. SPSS IBM version 20 was utilized to analyze the data. Each categorical item from the
questionnaire was summarized by frequency count and
percentage.
We used non-standardized criteria to diagnose the
disease. The 1990 American College of Rheumatology
and 2012 Chapel Hill Consensus Conference criteria for
the classification of the vasculitis have been accepted
[6], however they are not intended to be used as diagnostic criteria. The ACR criteriawas devised before the
widespread recognition of microscopic polyangiitis as a
separate disease as well as prior to recognition of antineutrophil cytoplasmic autoantibody (ANCA) testing
as a significant diagnostic tool. Therefore being a non
invasive test, we used serological evaluation as the initial
step for diagnosis of GPA at our institution. C-ANCA is
known to have sensitivity of 91% and specificity of 99%
for GPA [7]. Birmingham Vasculitis Activity Score version 3 (BVAS-v3) was used to determine the disease
activity. Outcomes recorded were death, cause of death
and number of relapses.
Results

During the study period, 51 patients diagnosed with
GPA were identified. The mean age of presentation was
44.0 ± 17.8 years with 23 males and 28 females. The
respiratory system was most commonly affected in 41
(80.4%) patients, followed by renal in 28 (54.9%), Ear
Nose and Throat (ENT) in 25 (49.0%), musculoskeletal system in 22 (43.1%), nervous system in 9 (17.6%),
integumentary system in 8 (15.7%) and ocular system
in 6 (11.8%) patients. Arthralgia was the most common
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presenting symptom seen in 21 patients followed by
cough in 16 patients. The clinical symptoms on presentation are as shown in Table 1.
All of the selected patients underwent both p-ANCA
and c-ANCA on initial work up. The c-ANCA was positive in all patients whilst only 11 patients were positive
with p-ANCA. Thirty three patients had a raised ESR
(> 20 mm/h). The radiological findings are outlined in
Table 2.
The most common finding on chest X-ray was pulmonary infiltrates seen in 16 patients (31.4%), followed by
pulmonary nodules, alveolar hemorrhages and cavitations in 9 patients each. A total of 13 biopsies were done
which included 7 renal, 3 nasal, 2 lung and 1 skin specimen. Four renal biopsies showed crescenteric glomerulonephritis, while focal necrotizing glomerulonephritis was
noted in 3 specimens. Chronic granulomatous remodeling along with necrotic change was well appreciated
in all the nasal biopsies. A mixed picture of acute and
chronic inflammation with scattered multinucleated
Table 1 Clinical manifestations of the patients with GPA
Clinical manifestations

Frequency (n)

Percentage (%)

ENT

25

49.0

Rhinosinusitis

6

11.8

Mucosal ulcers

1

2.0

Epistaxis

7

13.7

Hearing loss

9

17.6

Collapsed nasal bridge/saddle nose deformity

2

3.9

Pulmonary

41

80.4

Cough

16

31.9

Hemoptysis

9

17.6

Chest discomfort

7

13.7

Dyspnea

5

9.8

All

4

7.8

Renal

28

55.0

Hematuria

11

21.6

Renal failure

17

33.3

Ocular

6

11.8

Conjunctivitis

4

7.8

Episcleritis/uveitis

2

3.9

9

17.6

Cranial nerve palsies

4

7.8

Peripheral neuropathy

5

9.8

22

43.1

21

41.2

Neurological

Musculoskeletal
Arthritis/arthralgia
Myalgia

1

2.0

Cutaneous

8

15.7

Purpura/ecchymosis

6

11.8

Ulceration

2

3.9
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Table 2 Radiological
with GPA

manifestations

Parameters
Chest X-ray findings
Pulmonary infiltrates
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of

Frequency (n)

the

Percentage (%)

51

100

16

31.4

Diffuse alveolar hemorrhage

9

17.6

Nodules

9

17.6

Cavitations

9

17.6

Pleural effusion

4

7.8

Normal
Chest CT findings

patients

4

7.8

18

35.3

Nodules or masses

2

3.9

Airspace consolidation

6

11.8

Cavitation

5

9.8

Ground-glass Appearance

1

2.0

Bronchiectasis

4

7.8

giant cells and vasculitis could be identified in the lung
and skin biopsy results.
Forty five patients received a pulse dose (1 g/day) of
intravenous methyl prednisone. Remission was achieved
in 32 patients while 9 patients relapsed. Prednisolone
was the most common agent used for induction therapy
in 32 (62.6%) patients followed by cyclophosphamide
in 11 (21.6%) patients. Other therapies include Methotrexate, Rituximab, Plasma exchange and Azathioprine.
Prednisolone was the most common agent used for
maintenance therapy in 41 (80.3%) patients followed by
azathioprine in 8 patients (15.7%). The complications that
developed after the initiation of treatment were divided
into 3 categories: opportunistic infections, malignancy
and cytopenia. Sixteen patients developed opportunistic infections. Malignancies and cytopenia were noted
in four each. Nine patients passed away during the study
period; of these 5 deaths occurred due to respiratory failure, 3 deaths happened due to sepsis and 1 patient succumbed to heart failure. The median BVAS-v3 score at
presentation among all patients was 12.0 with range from
4.0 to 24.0. BVAS-v3 score was higher among patients
who expired compared to those who survived (14.1 vs.
11.1, P > 0.05). However the difference was insignificant
therefore we cannot conclude if the BVAS-v3 score at
presentation is useful in determining severity of disease
and in determining prognosis.
Discussion

This study, documenting 17 years of experience, is the
most comprehensive, single-institution study describing
the clinical and radiological characteristics, management,
and outcome of patients with GPA from the Pakistani
population. Respiratory manifestations were recorded

in 80% of our patients as compared to 50% involvement
observed in the literature whilst alveolar hemorrhage,
lung nodules, and respiratory failure were the key presenting features of this condition [8]. The second organ
system most commonly involved includes the kidneys
with focal segmental necrotizing glomerulonephritis being the most consistently presenting feature [10].
More than half of the patients (55%) in our study had
renal manifestations and one-third of them developed
renal failure. Our study reports 49% of the cases presenting with ENT manifestations. Hearing loss and epistaxis
were the most frequent symptoms. Previously, more than
70% of cases have been reported to have presented with
signs related to ENT ranging from crusting rhinorrhea
to damage of the facial cartilage causing deformities [11].
Other rare symptoms involved the mucocutaneous, nervous and ocular systems.
On radiological evaluation, 16 of 51 patients demonstrated pulmonary infiltrates in the form of consolidations making it the most common presentation in our
setting. Cordier et al reported pulmonary infiltrates to be
the second most common presentation making up 53%
of the patient population in their study [12]. In 1990 the
American College of Rheumatology endorsed a criterion
for the diagnosis of GPA. One of the clauses of the criteria was the presence of abnormal radiological findings
on chest X ray [13]. Chest CT is considered superior to
chest X-ray in the diagnosis of small vessel vasculitis [14].
Out of the 51 patients, 18 had an HRCT done. Six out of
18 patients showed airspace consolidation, making it the
most common finding. Multiple studies have shown that
abnormal radiological findings are found in 50–75% of
the population with GPA [15] with nodules and masses
being the two most common radiographic manifestations. Studies have also labeled the presence of bronchiectasis as a rare presentation [16] as supported by the
presence of bronchiectasis in only 4 patients in our study.
Moving on to serological investigations, ANCA testing has been employed as diagnostic criteria for GPA
at our institution. Anti-neutrophilic cytoplasmic antibody (ANCA) sensitivity can be as low as 60% in localized disease [17] whereas ANCA is both sensitive and
specific for GPA being present in 80–90% of patients
with systemic disease. Still, there are some reported
cases where the ANCA was negative [18]. A previous
study by Chloe et al showed an 80% c-ANCA positivity [19]. Prednisolone and Cyclophosphamide were the
most commonly used drugs for induction in 32 and
11 patients respectively. For severe disease, plasma
exchange in addition to oral corticosteroids and cyclophosphamide administration has been recommended
to halt the progression to end stage renal failure [20].
Oral corticosteroid therapy in conjunction with daily

81/80

–/79

–/11

c-ANCA/PR-3 positivity (%)

p-ANCA/MPO positivity (%)

47

14

Relapses,%

Expired,%

10

50

3

11

26

14

64

3

13

21

11

40

54

55

61

93

3/–

84

7

1966–1993

48

49/51

155

Reinold-Keller et al.
[6], Germany

NA

NA

7

4

39

10

41

68

75

81

90

11/12

76/73

NA

2000–2003

47

60/40

180

Stone et al.
(2002), USA

18

13

NA

1

48

25

11

70

63

27

21

7

93

4.7

2002–2010

44

35/25

60

Shobha et al.
(2018), India

NA

53

9

7

9

10

31

33

49

42

80

11/7

62/38

NA

2009–2014

46

42/58

45

Kumar et al.
(2015), India

17

31

12

6

30

19

41

31

68

44

79

9/7

82/62

3.1

2005–2016

40

43/57

105

Sharma et al.
[24], India

18

18

NA

NA

16

18

12

55

80

43

49

11/21

51/100

NA

2000–2017

44

55/45

51

Our study, 2018

c-ANCA, cytoplasmic antineutrophil cytoplasmic antibody; ENT, ear nose and throat; GIT, gastrointestinal tract; MPO, myeloperoxidase; p-ANCA, perinuclear antineutrophil cytoplasmic antibody; PR3, proteinase 3

10

7

Heart

GIT

30

Skin

17

40

39

14

Eye

60
60

67

77

Lung

Kidney

Nervous system

73

84

NA

ENT

98

4

Joints

Organ involvement (%)

6

4.75

Mean duration of follow
up, years

51
1996–2002

55

1995–2003

Mean age at diagnosis

50/50

445

Holle et al.[9],
Germany

Study period

396

54/46

Total no. of patients

Male/female %

Mahr et al. 2013,
Europe

Table 3 Comparison of clinical features of our GPA patients with other experiences
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oral cyclophosphamide or intravenous pulsatile cyclophosphamide is recommended for systemic disease
with organ dysfunction [20]. We had 33 cases maintained with prednisolone.
A literature review revealed a relative paucity of studies available on ANCA associated vasculitis from the
developing world. Our institution reported a 13 patient
registry in 2004 [21]. A 20 case series of Rhinological
manifestations of GPA was also reported from Rawalpindi in 2011 [22]. To our knowledge, this is the biggest
experience from Pakistan. Our neighboring Country,
India has reported three institutional experiences of
60, 45 and 105 patients. They also assessed the disease
activity and damage through the Birmingham Vasculitis
Activity Score v.3 (BVAS v. 3) [23, 24]. The Indian series
have been presented in Table 3 along with other ethnic
groups Table 3. Compares the summaries of GPA series
from literature. A comparable prevalence of organ system involvements are seen. In our opinion, tertiary care
centers need to maintain a registry of all the ANCA
associated vasculitis cases so that their clinical presentation and response to treatment can be well documented for our population.
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Conclusion

The results from our study indicate that GPA is not
uncommon in Pakistan. We believe that larger studies on
GPA will assist physicians in timely diagnosis and management of the disease.

Limitations
A few notable shortcoming of our study include the small
sample size making it difficult to develop significant associations between variables. Likewise, we report data from
only one tertiary care hospital of the country and so the
results we present cannot be generalized due to the possibility of referral bias.
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